Rapid selection of a pyrethroid metabolic enzyme CYP9K1 by operational malaria control activities by Vontas, John et al.
Rapid selection of a pyrethroid metabolic enzyme
CYP9K1 by operational malaria control activities
John Vontasa,b, Linda Grigorakia, John Morganc, Dimitra Tsakirelia, Godwin Fuseinid, Luis Segurad,
Julie Niemczura de Carvalhod, Raul Nguemae, David Weetmanc, Michel A. Slotmanf, and Janet Hemingwayc,1
aInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, 73100 Heraklion, Greece; bDepartment of Crop
Science, Agricultural University of Athens, GR-11855 Athens, Greece; cDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool L3
5QA, United Kingdom; dBioko Island Malaria Control Project, Medical Care Development International, Malabo, Equatorial Guinea; eMinistry of Health and
Social Welfare, Malabo, Equatorial Guinea; and fDepartment of Entomology, Texas A&M University, College Station, TX 77843
Contributed by Janet Hemingway, March 22, 2018 (sent for review November 14, 2017; reviewed by John M. Clark and Catherine A. Hill)
Since 2004, indoor residual spraying (IRS) and long-lasting
insecticide-impregnated bednets (LLINs) have reduced the malaria
parasite prevalence in children on Bioko Island, Equatorial Guinea,
from 45% to 12%. After target site-based (knockdown resistance;
kdr) pyrethroid resistance was detected in 2004 in Anopheles
coluzzii (formerly known as the M form of the Anopheles gambiae
complex), the carbamate bendiocarb was introduced. Subsequent
analysis showed that kdr alone was not operationally significant,
so pyrethroid-based IRS was successfully reintroduced in 2012. In
2007 and 2014–2015, mass distribution of new pyrethroid LLINs
was undertaken to increase the net coverage levels. The combined
selection pressure of IRS and LLINs resulted in an increase in the
frequency of pyrethroid resistance in 2015. In addition to a signif-
icant increase in kdr frequency, an additional metabolic pyrethroid
resistance mechanism had been selected. Increased metabolism of
the pyrethroid deltamethrin was linked with up-regulation of the
cytochrome P450 CYP9K1. The increase in resistance prompted a
reversion to bendiocarb IRS in 2016 to avoid a resurgence of
malaria, in line with the national Malaria Control Program plan.
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Malaria prevalence in Africa has been halved since 2000,with 80% of the reduction being the result of the use of
vector control (1). This reduction is primarily attributable to
pyrethroid-treated bed nets and indoor residual spraying (IRS).
Pyrethroid resistance in mosquito populations is at a critical
tipping point in Africa, threatening the progress made in re-
ducing malaria transmission (2, 3).
The most prevalent pyrethroid resistance mechanisms in
Anopheles affect the voltage-gated sodium channel target site of
the insecticide or its metabolic degradation pathway. Additional
resistance mechanisms include epicuticular changes, which slow
the uptake of pyrethroids (4). Knockdown resistance (kdr) mu-
tations at the target site typically alter the insecticide binding
affinity, and the most common in Anopheles are mutations
L1014F and L1014S in the voltage-gated sodium channel (5, 6).
In addition, the mutation N1575Y combined with L1014F
strengthens resistance to pyrethroids and dichlorodiphenyltri-
chloroethane (DDT) (7, 8), which used to be one of the most
widely used insecticides for malaria control and is still being used
in several parts of the world. Kdr resistance alone has not been
correlated with operational control failure in Anopheles gambiae.
The accumulation of kdr and metabolic resistance mechanisms,
however, have resulted in much higher pyrethroid resistance
levels, which may have an operational impact (9–11).
Overexpression of detoxification enzymes such as cytochrome
P450 monooxygenases (henceforth “P450s”) is frequently found
in association with metabolically based insecticide resistance in
An. gambiae (12). The P450 genes Cyp6M2 and Cyp6P3 are often
overexpressed in resistant An. gambiae (13), and both metabolize
permethrin and deltamethrin (14, 15). Cyp6Z2 is also sometimes
overexpressed, but binds/sequesters rather than metabolizes the
pyrethroids permethrin and cypermethrin (16).
Analysis of metabolic-resistance mechanisms typically involves
transcriptomic comparisons between resistant laboratory strains
or field-caught populations and laboratory susceptible strains
(17), with occasional examples of spatial or temporal compari-
sons made between field mosquitoes that differ in resistance
phenotype (18). In Burkina Faso, significant changes in expres-
sion of P450s were linked to an increase in pyrethroid resistance
(10), and, in Benin, expression of Cyp6M2 and Cyp6P3 increased
in An. gambiae after mass distribution of long-lasting insecticide-
treated nets (LLINs) (19). Kdr frequencies were unchanged in
both cases. An association between pyrethroid use and an in-
crease in the relative frequency of kdr 1014F and a nearly fixed
X-linked haplotype containing Cyp9K1 was demonstrated in a
genome-wide study of mosquitoes from Mali (20), but the role of
this P450 gene in resistance has not been established.
Before the Bioko Island Malaria Control Project (BIMCP)
and the Ministry of Health and Social Welfare established the
malaria control program in 2004, Bioko had one of the highest
entomological inoculation rates recorded in Africa, at ∼1,200
infectious bites per person per year (21). In 2004, there were
three major mosquito vector species on the island: Anopheles
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funestus and the M and S forms of An. gambiae, now elevated to
species as An. gambiae (S) and Anopheles coluzzii (M) (22).
Malaria prevention efforts used pyrethroid-impregnated LLINs
and IRS, with the carbamate bendiocarb or the pyrethroid del-
tamethrin (see Fig. 1 for timeline). A country-level operational
implementation of the World Health Organization (WHO)-
recommended Global Plan for Insecticide Resistance Manage-
ment (GPIRM) was established in 2012 (23), with insecticide
resistance monitoring providing robust data to support evidence-
based insecticide resistance management strategies.
Pyrethroid-based IRS was used when the program was initi-
ated, but resistance was quickly detected. Bendiocarb-based IRS
was instigated in the second spray round, but this switch in-
creased cost and reduced the effective longevity of the IRS. A
comprehensive study of the resistance mechanisms present in
An. gambiae from Bioko was conducted in 2011; kdr 1014F
genotypes were at high frequencies (28.5% FF, 57.14% LF), with
no significant metabolic resistance (23). With kdr alone expected
to have no operational impact on pyrethroid-based IRS efficacy,
the BIMCP reintroduced pyrethroids in 2012.
In 2015, bioassays indicated that pyrethroid resistance fre-
quency and level were increasing rapidly, which triggered de-
tailed analysis of the local vector population composition and
insecticide-resistance mechanisms to determine the appropriate
vector control interventions for 2016.
Results
Bioassays and Genotypes. A timeline for introduction of different
vector control activities in Bioko, overlaid on the annual malaria
prevalence figures for children 2–14 y old, is given in Fig. 1. There
were some issues with the pyrethroid IRS formulation in 2013,
which were corrected in 2014, but there were no indications from
bioassay data that resistance increased from 2013 to 2014.
The levels of insecticide resistance increased in 2015 compared
with earlier years, with mosquitoes from two field sites (hospital
and industrial) having <30%mortality after exposure to the WHO
discriminating dosage of deltamethrin but remaining susceptible
to bendiocarb (mortality rate > 99%; Table S1).
From the two sites where resistance was analyzed in detail, all
mosquitoes were identified as An. coluzzii (Table 1). All samples
collected in 2015 were homozygous for the L1014F kdrmutation,
but the L1014S and N1575Y and AChE G119S mutations were
not detected. This finding represents a significant increase in kdr
from 2011 (28.5% 1014F/F; χ22 = 46.5, P = 8 × 10−11; Table 1).
Annual island-wide surveys of kdr confirmed the increase in
frequency (Fig. 2) from 2011 to 2015.
Gene Expression. Several genes were overexpressed when the
Bioko field-collected populations were compared with the
insecticide-susceptible laboratory colonies. Of the 48 genes that
were significantly overexpressed in all comparisons performed,
four were P450s: Cyp6P4, Cyp9K1, Cyp6Z1, and Cyp6Z2 (Fig. 3
and Dataset S1). The up-regulation of each gene was assessed by
quantitative RT-PCR (qPCR). We also included Cyp6P3 in the
analysis as a strong pyrethroid metabolizer that narrowly missed
statistical significance in one of the four comparisons, in addi-
tion to the other known strong metabolizer, Cyp6M2, even
though this was not consistently differentially expressed. The
qPCR results confirmed the statistically significant up-regulation
of these P450 genes in most comparisons, with the exception of
Cyp6M2 (Fig. 4A).
We then compared expression levels of the same P450 genes
between the populations collected in 2011 and 2015 (Fig. 4B).
There was a significant and substantial elevation of expression of
Cyp9K1 and, to a lesser extent, of Cyp6P3 in 2015 samples
compared with 2011. Cyp6P4 showed a significant but slight
decrease in one site. The expression of the other P450s was
unchanged.
Functional Expression and Characterization of CYP9K1.As the role of
the Cyp9K1 gene in insecticide resistance had not been evaluated
previously to our awareness, CYP9K1 and An. gambiae cyto-
chrome P450 reductase (CPR) were functionally coexpressed in
Escherichia coli and directed to the inner bacterial membrane by
using the leading sequences ompA and pelB, respectively. The
reduced carbon monoxide-difference spectrum obtained indicated
that CYP9K1 was expressed predominately in its active P450 form,
characteristic of a well-folded and functional enzyme (Fig. S1A).
The isolated bacterial membranes contained 1.5 μM P450, whereas
the measured P450 reductase activity (AgCPR) was 136.5 μmol
cytochrome c reduced/min/g protein. CYP9K1 showed high activity
for the fluorescent substrate 7-ethoxycoumarin (Table 2).
CYP9K1 was able to metabolize 32% of the deltamethrin
applied following a 2-h incubation (Table 2). Deltamethrin me-
tabolism followed Michaelis–Menten kinetics (Km = 28.2 μΜ and
Vmax = 0.57 pmol deltamethrin/min/pmol P450; Fig. S1B).
CYP9K1 likewise metabolized pyriproxyfen, as observed by the
NADPH-dependent depletion of this insecticide (Table 2) and the
formation of two metabolites, which eluted at 6.2 min and 7.4 min,
respectively (24). In contrast, bendiocarb was not metabolized by
CYP9K1, with no substrate depletion after a 20-min incubation,
after which spontaneous, non–P450-specific, degradation occurred.
Discussion
Bioko Island is implementing a country-level operational imple-
mentation of the GPIRM with evidence-based malaria vector
control. A robust program for insecticide resistance monitoring
has been in place since 2004 (23). In 2011, pyrethroids were still
operationally functional, and the BIMCP rotated back to pyre-
throid IRS in 2012 after 7 y of bendiocarb use to maintain levels of
disease control, reduce cost, and reduce the selection pressure on
bendiocarb. Three years later, after bioassays signaled a change in
pyrethroid-resistance status of the local vector (deltamethrin
mortality rate of 25.7% in 2015 vs. 40% in 2011) but detected no
difference in the susceptibility to bendiocarb (Table S1), a detailed
insecticide-resistance analysis was undertaken. The frequency of
Fig. 1. Timelines for vector-control events and Plasmodium falciparum
parasite prevalence data in 2–14-y-old children in 2004–2016. Arrows in-
dicate major vector control events over time in Bioko. Pyr, pyrethroids; R,
resistance.
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the target site pyrethroid resistance mutation L1014F was dra-
matically higher in 2015 (100% in 2015 and 57% in 2011 at the
same collection sites), but the Anopheles pyrethroid kdr-based
resistance enhancing mutation N1575Y and the AChE resistance
mutation (G119S) were not found. The P450s Cyp6P4, Cyp9K1,
Cyp6Z1, Cyp6Z2, and Cyp6P3 were overexpressed in An. coluzzii
from Bioko compared with the susceptible colonies (N’gusso and
Kisumu), indicating a possible link to the increased pyrethroid
resistance. Specific P450 genes are repeatedly implicated in py-
rethroid resistance in An. gambiae and An. coluzzii populations
(13), and, in some cases, single P450s have been demonstrated to
confer resistance via heterologous expression in Drosophila (9). In
resistant mosquito field populations, however, multiple P450s are
typically overexpressed to moderate levels, in contrast with Dro-
sophila and agricultural pest examples, in which resistance is often
attributed to dramatic elevation of single P450s (25, 26).
In the “hospital 2015” and “industrial 2015” An. coluzzii
populations, there was a 6–10-fold increase in expression of
Cyp9K1, and lower, but significant, overexpression of Cyp6P3
compared with mosquitoes sampled from the same regions in
2011. Selection by pyrethroid-based IRS and more recently
LLINs in Bioko may have given rise to this metabolic resistance
coupled with an increase in kdr frequency. Resistance is likely to
have arisen de novo in An. coluzzii on the island, as there is no
evidence over several years of An. funestus or An. gambiae s.s.
reinvading from the mainland after local elimination, coupled
with previous evidence of a de novo local origin of kdr 1014F
(27). The situation on Bioko is one of very few examples of
documented changes in metabolic gene expression linked to
control interventions.
Relatively few candidate genes in An. gambiae spp. have been
subjected to functional validation, without which a definitive
causal link with insecticide resistance cannot be made.
CYP9K1 was able to metabolize deltamethrin (Kcat, 0.57 min
−1;
Km, 28.2 μM), albeit with lower in vitro catalytic efficiency
compared with other major P450s linked with resistance,
CYP6P3 (Kcat, 1.8 min
−1; Km, 5.9 μM) (14) and CYP6M2 (Kcat,
1.1 min−1; Km, 2 μM) (15). However, the actual in vivo contri-
bution of each P450 to the resistance phenotype is a more
complex issue, as factors such as tissue localization of each en-
zyme may affect the resistance phenotype. Moreover, combined
metabolic activity of more than one P450 on pyrethroid sub-
strates and their metabolites has been reported (28, 29), which
might also be the case here, perhaps mediated by synergistic in-
teraction with the other overexpressed enzyme, CYP6P3. An in-
teresting consideration for alternative interventions is that
CYP9K1 was also able to metabolize the juvenile hormone analog
pyriproxyfen, in line with other major cytochrome P450 metabolic
enzymes (30). This result is a concern because pyriproxyfen is
being combined with pyrethroids in some next-generation LLINs.
CYP9K1 did not metabolize bendiocarb and CYP6P3 has very low
catalytic efficiency for bendiocarb (9), consistent with the absence
of phenotypic resistance.
It has been hypothesized that the coevolution of P450s and
target-site resistance mutations can lead to high levels of re-
sistance that challenge operational efficacy of pyrethroids (20,
31). When metabolic pyrethroid resistance was first selected in
Africa, Cyp9K1 did not appear to be a strong indicator of met-
abolic resistance in An. gambiae, a pattern that may now be
changing. In addition to the present data from Bioko, Cyp9K1
was found to be up-regulated in DDT-resistant An. gambiae and
An. coluzzii populations from Cameroon possessing kdr 1014F
(32) and also in deltamethrin-resistant but kdr-free Anopheles
parensis from Uganda (33). A section of the X-chromosome that
included Cyp9K1 was detected as being under positive selection,
together with the L1014F kdr mutation, in An. coluzzii pop-
ulations fromMali after an increase in insecticide pressure by the
Table 1. Molecular form composition and frequencies of target-site resistance mutations in
field-caught An. gambiae s.l. populations collected in Bioko
Population
Genotypes Target-site allele frequency, %*
No. of
specimens
Molecular
form, %
No. of
specimens 1014F/F 1014F/L 10114L/LM/M S/S
Malabo 2004† — 36 64 4,500 14 41 45
Malabo 2011 75 100 0 75 28.5 57.14 14.3
Malabo hospital 2015 16 100 0 16 100 0 0
Malabo industrial 2015 16 100 0 16 100 0 0
M, An. coluzzii (M form); S, An. gambiae s.s. (S form).
*Data from Hemingway et al., 2013 (23).
†Mutations L1014S and N1575Y on the voltage-gated sodium channel, as well as mutation G119S on
acetylcholinesterase, were absent in all alleles (n > 200) genotyped in both 2011 and 2015. F/F, individuals
homozygous for mutation L1014F on the voltage-gated sodium channel; F/L, heterozygotes; L/L, homozygous
individuals for the WT (i.e., susceptible) allele.
Fig. 2. Frequency of the L1014F kdr mutation in A. coluzzii on Bioko Island,
2009–2015. Data generated from combined routine island-wide annual en-
tomological surveillance data and the more detailed studies undertaken in
2011 and 2014 at two sites in Malabo. Arrows indicate time points at which
new pyrethroid-based operational IRS and LLIN control interventions oc-
curred.
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widespread use of insecticide-treated nets with pyrethroids (20).
This growing body of evidence suggesting a role for CYP9K1 in
resistance is now further supported by demonstration of func-
tional expression and metabolic activity.
In 2004, the majority of malaria mosquito vectors collected on
Bioko were An. gambiae s.s. In 2015, An. coluzzii and Anopheles
melas were the only vector species collected. Hence, the vector-
control activities may now have eliminated An. funestus and An.
gambiae s.s. from the island. In Mali, Cyp9k1 was selected as an An.
coluzzii haplotype from standing variation, rather than via in-
trogression from An. gambiae (20). On Bioko, the simultaneous
detection of increased Cyp9k1 expression, coupled with an increase
in kdr 1014F frequency and higher levels of pyrethroid resistance,
suggests that the two mechanisms may act synergistically.
Conclusion
The change in the resistance profile of An. coluzzii observed over
a period of 3 y after pyrethroid IRS was reinstated is mediated by
target site and metabolic resistance mechanisms involving a
newly validated cytochrome P450 pyrethroid metabolizer,
CYP9K1. In line with the national evidence-based resistance
management plan, a recommendation that a nonpyrethroid IRS
formulation should be used in 2016 was made. The susceptibility
of An. coluzzii and An. melas vectors to organophosphates and
carbamates indicates that bendiocarb or the longer-lasting formulation of
Actellic 300CS (34) are the best alternatives.
Materials and Methods
Malaria Prevalence Surveys. Annual malaria prevalence surveys in children 2–
14 y of age were undertaken as described by Bradley et al. (35). Informed
consent was obtained from all participants. Annual parasite prevalence
surveys are covered by ongoing IRB clearance through the Ministry of Health
and Marathon Oil Malaria elimination programme in Equatorial Guinea,
which has been in place since 2003.
Mosquito Collections and Bioassays. Island-wide routine entomological
monitoring was undertaken annually from 2009 to 2015 to assess species
composition and the frequency of the kdr-pyrethroid resistance mechanism.
More intensive analysis of resistance was undertaken in 2004, 2011, and
2014 at more limited sites in response to changes in resistance levels detected
in routine surveys. For the intensive surveys, immature Anopheles were
collected from the same sites each year: the grounds of the general hospital
in the Ela Nguema district of Malabo (03°45.583 N, 008°47.364 E; referred to
as “hospital”) and a former industrial site along the harbor (03°45.325 N,
008°46.003 E; “industrial”). Both sites are in the center of Malabo, close to
housing. Field-collected larvae were reared to adulthood, and 3-d-old non–
blood-fed females were bioassayed by using the WHO susceptibility tests
(36). Briefly, mosquitoes were exposed to insecticide-impregnated papers
(0.05% deltamethrin or 0.1% bendiocarb; WHO recommended doses) for
1 h, and mortality rates were recorded 24 h later.
Fig. 3. Significantly up-regulated transcripts found in field-caught resistant populations. Transcripts were found to be significantly up-regulated in the
hospital 2015 and industrial 2015 populations in all comparisons performed with the two susceptible laboratory colonies N’gusso and Kisumu. The average
log(2) FC between resistance and susceptible replicates is shown. Detoxification genes are highlighted in red.
Fig. 4. Expression analysis of selected P450s by qPCR. (A) qPCR comparisons
of selected P450 transcripts between hospital 2015 and industrial 2015 An.
gambiae field populations from Bioko vs. the two susceptible laboratory
colonies (N’gusso, Kisumu). Error bars represent the SE based on four bi-
ological replicates. Asterisk indicates a statistically significant difference in
expression levels between the tested samples (Mann–Whitney U test, P <
0.05). (B) Comparison of P450 transcript expression levels between field-
caught populations in 2015 (hospital and industrial) vs. samples collected in
2011. Error bars represent the SE based on four biological replicates. Asterisk
indicates a statistically significant difference in expression levels between
the tested samples (Mann–Whitney U test, P < 0.05).
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Molecular Genotyping for Species Identification and Target Site Resistance
Mutations. An. gambiae s.l. were identified by using a PCR-based di-
agnostic assay (37) with An. gambiae s.s. and An. coluzzii, two members of this
complex subsequently separated by using the short interspersed element
(SINE) PCR method (38). SINE PCR is needed because the two species are
morphologically indistinguishable. TaqMan assays with probes detecting the
mutant resistant allele and the WT susceptible allele were used to screen for
the presence of three kdr mutations (L1014F, L1014S, N1575Y) and the G119S
AChE mutation conferring resistance to pyrethroids and DDT and to organo-
phosphates, respectively (7, 39).
Analysis of Gene Expression (Metabolic Resistance). Three-day-old field-
caught, non–blood-fed female mosquitoes were compared with adult
females of the same age from the N’gusso (An. coluzzii ) and Kisumu (An.
gambiae s.s.) insecticide-susceptible laboratory colonies. Total RNA was
extracted from four replicate batches of 10 mosquitoes from each group
(N’gusso, Kisumu, hospital, and industrial) by using a PicoPure RNA iso-
lation kit (Thermo Fisher Scientific) and treated with DNase using the
Qiagen RNase-free DNase kit according to the manufacturer’s instruc-
tions. RNA quantity and quality were evaluated with a NanoDrop spec-
trophotometer (Thermo Fisher Scientific) and a model 2100 Bioanalyzer
(Agilent Technologies). RNA pools from each group were amplified and
labeled by using the Low Input Quick Amp Labeling Kit (Agilent Tech-
nologies). The Agilent Agam15k array (40) was used for dual-color hy-
bridizations (hospital vs. N’gusso, hospital vs. Kisumu, industrial vs.
N’gusso, and industrial vs. Kisumu). Each mosquito population compar-
ison was repeated four times.
Agilent Feature Extraction Software v12 and GeneSpring v13 were used
for the analysis of themicroarray data. Significance was determined by a one-
sample t test (against the null hypothesis, which was a ratio of field/colony
sample expression of 1) with the P value threshold set at P < 0.05 following
correction for multiple testing (Benjamini–Hochberg method). A fold change
(FC) criterion of FC > 2 or FC < −2 (for underexpressed probes) was used.
RNA was reverse-transcribed by using SuperScript III (Invitrogen) and
oligo(dT)20 primers to produce cDNA. Expression of candidate genes from
the microarray analysis was validated by qPCR (primers listed in Table S2) and
normalized using the Ribosomal S7 (AGAP010592) and Elongation Factor
(AGAP005128) reference genes (10). Mosquito samples from 2011, before
the reintroduction of deltamethrin in 2012, were included in this analysis to
allow direct comparisons between temporally separated field-caught sam-
ples. Experiments were performed by using four biological replicates from
each treatment group and two technical replicates for each reaction. Rela-
tive expression analysis was performed according to ref. 41.
Functional Expression of CYP9K1. cDNA from the adult hospital population
was used as a template to amplify the full-length Cyp9K1 by using a proof
reading polymerase (Kappa Taq DNA polymerase, long range) and primers
listed in Table S2. The hospital strain was used because it had the highest
levels of CYP activity. Conditions of amplification were 94 °C for 2 min,
followed by 30 cycles of denaturation at 94 °C for 25 s, annealing at 54 °C for
15 s, and extension at 72 °C for 2 min, followed by a final extension step for
5 min. Primers used for the amplification introduced a EcoRI restriction site
before the start ATG codon and an XbaI site after the stop codon. The purified
PCR product (NucleoSpin PCR and gel extraction purification; Macherey–Nagel)
was ligated into the pCWompA2 expression plasmid (16) and sequenced.
For protein expression, the strategy described in ref. 42 was followed by
using E. coli BL21STAR cells cotransformed with the pCWompA2-Cyp9K1
P450 and the pACYC-AgCPR (expression plasmid for the An. gambiae CPR).
Membrane preparations were tested for total protein concentration (43),
P450 concentration (44), and CPR activity (45).
Cytochrome P450 Activity and Insecticide Metabolism Measurements. Activity
of recombinant CYP9K1 against the fluorogenic P450 substrate 7-ethox-
ycoumarin and eight different luciferin-conjugated substrates (P450 Glo
proluciferin substrates Luciferin-H, Luciferin-ME, Luciferin-CEE, Luciferin-H
EGE, Luciferin-PFBE, Luciferin-PPXE, Luciferin-ME EGE, and Luciferin-IPA;
Promega) was measured (42).
Metabolism of deltamethrin, bendiocarb, and the insect growth regulator
pyriproxyfen by CYP9K1 was measured. Deltamethrin (10 μM Fluka; Pesta-
nal), bendiocarb (10 μM Fluka; Pestanal), and pyriproxyfen (50 μM Fluka;
Pestanal) were incubated with 25 pmol recombinant CYP9K1 and 200 pmol
b5 (AgCytb5; GB AY183376) in 100 μL Tris·HCl buffer (0.2 M, pH 7.4), con-
taining 0.25 mM MgCl2. The incubation was performed in the presence and
absence of an NADPH generating system: 1 mM glucose-6-phosphate
(Sigma-Aldrich), 0.1 mM NADP+ (Sigma-Aldrich), and 1 U/mL glucose-6-
phosphate dehydrogenase (G6PDH; Sigma-Aldrich). Reactions were in-
cubated at 30 °C, agitated at 9,600 × g oscillation, and stopped at different
time points by using 100 μL acetonitrile. The quenched reactions were
centrifuged at 9,600 × g (MicroCL 17R centrifuge; Thermo Scientific) for
10 min, and 100 μL of the supernatant was assessed by HPLC by using a
UniverSil HS C18 (250 mm 5 μm) reverse-phase analytical column (Fortis).
Reactions with deltamethrin were run with an isocratic mobile phase of 10%
H2O and 90% acetonitrile with a flow rate of 1 mL/min for 20 min. Delta-
methrin elution was monitored at 225-nm absorbance at a retention time of
9.8 min. Reactions with bendiocarb were run with an isocratic mobile phase
of 65% H2O and 35% acetonitrile with a flow rate of 1 mL/min for 20 min.
Bendiocarb elution was monitored at 205-nm absorbance at a retention
time of 17.2 min. Reactions with pyriproxyfen were run with an isocratic
mobile phase of 30% H2O and 70% acetonitrile with a flow rate of 1.5 mL/min
for 25 min. Pyriproxyfen elution was monitored at 232-nm absorbance and at
a retention time of 18.1 min. For kinetics of deltamethrin, varying concen-
trations of substrate were used (0.5–150 μM). Rates of deltamethrin turnover
were plotted vs. deltamethrin substrate concentrations, and the kinetic pa-
rameters Km and Vmax were determined by using SigmaPlot 12.0 (Systat
Software) by fitting to the Michaelis–Menten equation.
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